Evotec (OTCMKTS:EVTCY) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.62 and traded as low as $1.8389. Evotec shares last traded at $1.86, with a volume of 121,907 shares.

Evotec Stock Down 2.1%

The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm has a market cap of $614.21 million, a price-to-earnings ratio of 4.54 and a beta of 0.98. The firm has a 50-day moving average of $2.15 and a two-hundred day moving average of $2.62.

About Evotec

(Get Free Report)

Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.

The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.

See Also

• Five stocks we like better than Evotec
• 3 Under-the-Radar Defense Stocks With Record Backlogs
• This Korea ETF Has Soared, But the Rally May Not Be Over
• Why Guidewire’s Post-Earnings Plunge May Not Last
• Ride-Share Reckoning: Tesla Drives Into Uber’s Lane